EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Changes in management of idiopathic pulmonary fibrosis: impact on disease severity and mortality

Charlotte Hyldgaard iD, Janne Møller iD, Elisabeth Bendstrup iD

European Clinical Respiratory Journal · 01.01.2020 · 7 (1) · 1807682

DOI: 10.1080/20018525.2020.1807682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Clinical Respiratory Journal, online erschienen am 12.08.2020. Verfasst von Charlotte Hyldgaard und 2 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic Center, University Research Clinic for Innovative Patient Pathways, Silkeborg Regional Hospital, Silkeborg, Denmark. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a serious interstitial lung disease (ILD) with a median survival of 3-5 years. The aim of the present study was to evaluate disease severity and survival in patients diagnosed with IPF in the era of antifibrotic therapies compared with an earlier IPF cohort. METHODS: We identified all patients with fibrotic ILD in the hospital electronic case record system between 2011 and 2016, and reviewed each case in order to identify incident patients with IPF. We used the GAP-index to compare disease severity and mortality to previous findings in patients with IPF diagnosed at our center between 2003 and 2009. RESULTS: 260 patients were diagnosed with IPF between 2011 and 2016. Mean age was 72.6 years, 79% were male, mean forced vital capacity (FVC) was 80%, and mean diffusing capacity for carbon monoxide (DLco) was 44%. Age, FVC and DLco were significant predictors of mortality, but the presence of a typical usual interstitial pneumonia pattern on HRCT was not. Eighty percent of patients in GAP stage I received antifibrotic therapy, 73% in GAP stage II, and 29% in GAP stage III.The median survival was four years in the 2011-2016 cohort compared with three years in the 2003-2009 cohort. The distribution of patients between GAP stages was unchanged in 2011-2016 compared with 2003-2009, (stage I 34% vs. 32%, stage II 49% vs. 48% and stage III 20% vs. 16%). One-year mortality was 13% in 2011-2016 and 26% in 2003-2009. In severe disease (GAP stage III), one-year mortality was 26% and 54%, respectively, (p=0.019). CONCLUSION: Short-term mortality was significantly lower in the 2011-2016 cohort compared with 2003-2009. This improvement may be linked to changes in treatment strategies towards limited use of corticosteroids. Although early diagnosis of IPF still needs increased focus, the improvement is encouraging.

Schlagwörter

Stichwörter der Autor:innen

Idiopathic pulmonary fibrosisantifibrotic therapyinterstitial lung diseasemortality

Autor:innen und Institutionen

  • Diagnostic Center, University Research Clinic for Innovative Patient Pathways, Silkeborg Regional Hospital, Silkeborg, Denmark.
  • Center for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.

ORCID-Profile: Charlotte Hyldgaard, Janne Møller, Elisabeth Bendstrup

Zitieren

APA

Hyldgaard, C., Møller, J., & Bendstrup, E. (2020). Changes in management of idiopathic pulmonary fibrosis: impact on disease severity and mortality. European Clinical Respiratory Journal, 7(1), 1807682. https://doi.org/10.1080/20018525.2020.1807682

Vancouver

Hyldgaard C, Møller J, Bendstrup E. Changes in management of idiopathic pulmonary fibrosis: impact on disease severity and mortality. European Clinical Respiratory Journal. 2020;7(1):1807682. doi:10.1080/20018525.2020.1807682

BibTeX
@article{Hyldgaard2020,
  author = {Hyldgaard, Charlotte and Møller, Janne and Bendstrup, Elisabeth},
  title = {Changes in management of idiopathic pulmonary fibrosis: impact on disease severity and mortality},
  journal = {European Clinical Respiratory Journal},
  year = {2020},
  volume = {7},
  number = {1},
  pages = {1807682},
  doi = {10.1080/20018525.2020.1807682}
}
Kostenlos starten →